Literature DB >> 26163961

Pursestring Closure versus Conventional Primary Closure Following Stoma Reversal to Reduce Surgical Site Infection Rate: A Meta-analysis of Randomized Controlled Trials.

Meng-Chiao Hsieh1, Liang-Tseng Kuo, Ching-Chi Chi, Wen-Shih Huang, Chih-Chien Chin.   

Abstract

BACKGROUND: Stoma reversal is a surgical procedure commonly used following temporary defunctioning stoma surgery. Surgical site infection is one of the most common postoperative morbidities. A few skin closure methods have been developed to decrease surgical site infection. However, the optimal skin closure method is still in debate.
OBJECTIVE: The aim of this study was to compare the surgical site infection rate and other postoperative outcomes between the pursestring closure and conventional primary closure techniques. DATA SOURCES: We searched the MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials for relevant trials. STUDY SELECTION: We conducted a meta-analysis of randomized controlled trials that compared the surgical outcomes following pursestring closure and conventional primary closure techniques. INTERVENTION: We conducted the meta-analysis by using the random-effects model. MAIN OUTCOME MEASURES: The primary outcome of interest was surgical site infection following stoma reversal within 30 days after operation.
RESULTS: This meta-analysis included 4 randomized controlled trials with a total of 319 participants (162 in the pursestring closure group and 157 in the conventional primary closure group). Compared with the conventional primary closure group, the pursestring closure group had a significant decrease in surgical site infection (risk difference, -0.25; 95% CI, -0.36 to -0.15; p < 0.00001; number needed to treat = 4) and higher satisfaction with cosmetic outcomes (standard mean difference, 0.7; 95% CI, 0.13-1.27; p = 0.02). No other significant differences in operative time, length of hospital stay, and wound healing time were found between the 2 groups. LIMITATIONS: This study was limited to the lack of double blinding and long-term follow-up in the included trials.
CONCLUSIONS: Pursestring closure has significantly fewer surgical site infections and achieves better cosmetic outcomes following stoma reversal than conventional primary closure.

Entities:  

Mesh:

Year:  2015        PMID: 26163961     DOI: 10.1097/DCR.0000000000000401

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  17 in total

1.  Colostomy is a simple and effective procedure for severe chronic radiation proctitis.

Authors:  Zi-Xu Yuan; Teng-Hui Ma; Huai-Ming Wang; Qing-Hua Zhong; Xi-Hu Yu; Qi-Yuan Qin; Jian-Ping Wang; Lei Wang
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  The effect of purse-string approximation versus linear approximation of ileostomy reversal wounds on morbidity rates and patient satisfaction: the 'STOMA' trial.

Authors:  D P O'Leary; M Carter; D Wijewardene; M Burton; D Waldron; E Condon; J C Coffey; C Peirce
Journal:  Tech Coloproctol       Date:  2017-11-17       Impact factor: 3.781

Review 3.  Italian guidelines for the surgical management of enteral stomas in adults.

Authors:  F Ferrara; D Parini; A Bondurri; M Veltri; M Barbierato; F Pata; F Cattaneo; A Tafuri; C Forni; G Roveron; G Rizzo
Journal:  Tech Coloproctol       Date:  2019-10-12       Impact factor: 3.781

Review 4.  Considerations in Stoma Reversal.

Authors:  Karen L Sherman; Steven D Wexner
Journal:  Clin Colon Rectal Surg       Date:  2017-05-22

5.  Risk factor for the development of surgical site infection following ileostomy reversal: a single-center report.

Authors:  Shuangming Lin; Dongbo Xu; Yibin Zhu; Jianxun Chen
Journal:  Updates Surg       Date:  2022-08-24

Review 6.  Early Closure of Defunctioning Loop Ileostomy: Is It Beneficial for the Patient? A Meta-analysis.

Authors:  Benjamin Menahem; Jean Lubrano; Antoine Vallois; Arnaud Alves
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

Review 7.  Multidisciplinary management of elderly patients with rectal cancer: recommendations from the SICG (Italian Society of Geriatric Surgery), SIFIPAC (Italian Society of Surgical Pathophysiology), SICE (Italian Society of Endoscopic Surgery and new technologies), and the WSES (World Society of Emergency Surgery) International Consensus Project.

Authors:  Mauro Podda; Patricia Sylla; Gianluca Baiocchi; Michel Adamina; Vanni Agnoletti; Ferdinando Agresta; Luca Ansaloni; Alberto Arezzo; Nicola Avenia; Walter Biffl; Antonio Biondi; Simona Bui; Fabio C Campanile; Paolo Carcoforo; Claudia Commisso; Antonio Crucitti; Nicola De'Angelis; Gian Luigi De'Angelis; Massimo De Filippo; Belinda De Simone; Salomone Di Saverio; Giorgio Ercolani; Gustavo P Fraga; Francesco Gabrielli; Federica Gaiani; Mario Guerrieri; Angelo Guttadauro; Yoram Kluger; Ari K Leppaniemi; Andrea Loffredo; Tiziana Meschi; Ernest E Moore; Monica Ortenzi; Francesco Pata; Dario Parini; Adolfo Pisanu; Gilberto Poggioli; Andrea Polistena; Alessandro Puzziello; Fabio Rondelli; Massimo Sartelli; Neil Smart; Michael E Sugrue; Patricia Tejedor; Marco Vacante; Federico Coccolini; Justin Davies; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-07-02       Impact factor: 5.469

8.  Evidence-based adoption of purse-string skin closure for stoma wounds.

Authors:  Nilotpal Behuria; Jayant Kumar Banerjee; Sita Ram Ghosh; Shrirang Vasant Kulkarni; Ramanathan Saranga Bharathi
Journal:  Med J Armed Forces India       Date:  2019-06-03

9.  Temporary closure of colostomy with suture before colostomy takedown improves the postoperative outcomes.

Authors:  Wan-Hsiang Hu; Ko-Chao Lee; Kai-Lung Tsai; Hong-Hwa Chen
Journal:  Int J Colorectal Dis       Date:  2017-11-22       Impact factor: 2.571

10.  Risk Factors of Delayed Recovery of Gastrointestinal Function After Ileostomy Reversal for Rectal Cancer Patients.

Authors:  Lili Chu; Hui Wang; Suyu Qiu; Biyan Shao; Jia Huang; Qiyuan Qin; Yanjiong He; Jing Xue; Xiaoyan Li; Xiaoyan Huang; Rongkang Huang
Journal:  Cancer Manag Res       Date:  2021-06-29       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.